NCLEX-PN
NCLEX PN Practice Questions Questions
Extract:
Question 1 of 5
The nurse is monitoring a 12-month-old diagnosed with intussusception. Which findings should the nurse expect? Select all that apply.
Correct Answer: B,D,E
Rationale: Intussusception is characterized by a sausage-shaped mass, paroxysmal pain with knee-drawing, and 'currant jelly' stools.
Question 2 of 5
The nurse is offering safety instructions to a parent with a four month-old infant and a four year-old child. Which statement by the parent indicates understanding of appropriate precautions to take with the children?
Correct Answer: D
Rationale: The infant seat is to be placed on the rear seat. Small children and infants are not to be left unsupervised. Option D indicates supervision and age-appropriate responsibility.
Question 3 of 5
A young Spanish-speaking client is experiencing a spontaneous abortion (miscarriage). Which illustrates the best use of an interpreter to explain the situation to the client? Select all that apply.
Correct Answer: B,C,E
Rationale: A female interpreter respects cultural sensitivity, eye contact with the client fosters trust, and teaching one intervention at a time aids understanding. Friends/relatives as interpreters violate HIPAA.
Question 4 of 5
The nurse is caring for a 72-year-old client 1 day postoperative colectomy. The nurse finds increased work of breathing, diminished breath sounds at the bases with fine inspiratory crackles, respirations 12/min and shallow, and pulse oximetry 96% on 2 L oxygen. There is no jugular venous distension or peripheral edema. Pain is regulated with client-controlled morphine. Which prescription does the nurse anticipate?
Correct Answer: B
Rationale: Incentive spirometry promotes lung expansion and prevents atelectasis, which is likely causing the observed respiratory symptoms.
Question 5 of 5
A client with leukemia has been receiving injections of Neulasta (pegfilgrastim). Which laboratory value reveals that the drug is producing the desired effect?
Correct Answer: B
Rationale: Neulasta (pegfilgrastim) stimulates the production of neutrophils, a type of white blood cell, to reduce the risk of infection in clients with neutropenia. A white blood cell count of 6,000/mm indicates an increase in white blood cells, showing the drug's desired effect. Hemoglobin relates to red blood cells, platelet count relates to clotting, and iron level is unrelated to Neulasta's action.